Discover 3,573 paid clinical trials in Anaheim, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With research focusing on conditions such as chronic pain management, lymphoma, cardiovascular diseases, and mental health disorders, Anaheim offers many opportunities for both healthy volunteers and those looking for trials focused on specific health conditions. By joining a study, participants can access innovative treatment options and contribute to healthcare advancements in areas that matter most.
Filter
2
Filter results
Results: 3,573
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
for
FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers,
Location: Fullerton CA, Irvine CA, Los Angeles CA, Rochester MN,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18 - 70+
Code: NCT07322094
Phase 1, Phase 2, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Fullerton CA, Los Angeles CA, Murrieta CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
FT839 in Autoimmune Diseases
for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07800871
Phase 1, Phase 2, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Fullerton CA, Orange CA, Los Angeles CA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Fullerton CA, Huntington Beach CA, Upland CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Fullerton CA, Orange CA, Duarte CA, Santa Monica CA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Fullerton CA, Los Angeles CA, Billings MT, Seattle WA,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Fullerton CA, Orange CA, Phoenix AZ, Fort Worth TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Fullerton CA, Orange CA, Mission Viejo CA, Burbank CA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Fullerton CA, Whittier CA, Newport Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Fullerton CA, Newport Beach CA, La Jolla CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Fullerton CA, Los Alamitos CA, Fountain Valley CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Fullerton CA, Vista CA, Encinitas CA, San Diego CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Fullerton CA, Los Angeles CA, Panorama City CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase 1, Phase 2, Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Fullerton CA, Tacoma WA, Spokane WA, Tyler TX,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Location: Fullerton CA, Irvine CA, Los Angeles CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT06308978
Phase 1, Recruiting
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
for
Covid19
Location: Fullerton CA, Santa Monica CA
Sponsor: Stemedica Cell Technologies, Inc.
Sex: All
Age: 18+
Code: NCT04780685
Phase 2, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.